Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling. [PDF]
Deguchi R +7 more
europepmc +1 more source
Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes. [PDF]
Zhou Y +8 more
europepmc +1 more source
Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis. [PDF]
Han NR, Park HJ, Ko SG, Moon PD.
europepmc +1 more source
Oncostatin M receptor-dependent signaling assessed by RNA sequencing in mouse hematopoietic stem cells. [PDF]
Schwartz LS +4 more
europepmc +1 more source
Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis. [PDF]
Huynh NC +15 more
europepmc +1 more source
Oncostatin M promotes epithelial barrier dysfunction in patients with eosinophilic chronic rhinosinusitis with nasal polyps. [PDF]
Wang BF, Wang YY, Lin H, Yi YL.
europepmc +1 more source
Oncostatin M for Anti-HBV Therapy: Can a Foe Be Turned Into a Friend? [PDF]
Cheng T, Cheng Y, Jin DY.
europepmc +1 more source
Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems. [PDF]
Sims NA, Lévesque JP.
europepmc +1 more source
Oncostatin M signaling drives cancer-associated skeletal muscle wasting. [PDF]
Domaniku-Waraich A +8 more
europepmc +1 more source
Targeting Oncostatin M Receptor to Attenuate Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine. [PDF]
Trinh J, Shin J, Rai V, Agrawal DK.
europepmc +1 more source

